192 related articles for article (PubMed ID: 35186165)
1. Prognostic and Clinical Significance of Aspartate Aminotransferase-to-Lymphocyte Ratio Index in Individuals with Liver Cancer: A Meta-Analysis.
Peng X; Huang Y; Zhang M; Chen Y; Zhang L; He A; Luo R
Dis Markers; 2022; 2022():3533714. PubMed ID: 35186165
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
3. Postoperative aspartate aminotransferase to lymphocyte ratio index change is an independent predictor of survival in patients with small hepatocellular carcinoma.
He C; Peng W; Li C; Wen TF
Medicine (Baltimore); 2017 Nov; 96(45):e8540. PubMed ID: 29137062
[TBL] [Abstract][Full Text] [Related]
4. Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection.
Jin J; Zhu P; Liao Y; Li J; Liao W; He S
Oncotarget; 2015 Aug; 6(22):19217-27. PubMed ID: 26057470
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of γ-glutamyl transpeptidase to albumin ratio combined with aspartate aminotransferase to lymphocyte ratio in patients with hepatocellular carcinoma after hepatectomy.
Liu KJ; Lv YX; Niu YM; Bu Y
Medicine (Baltimore); 2020 Nov; 99(48):e23339. PubMed ID: 33235099
[TBL] [Abstract][Full Text] [Related]
6. Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization.
Yang Z; Zhang J; Lu Y; Xu Q; Tang B; Wang Q; Zhang W; Chen S; Lu L; Chen X
Oncotarget; 2015 Dec; 6(40):43090-8. PubMed ID: 26506519
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of aspartate aminotransferase-to-lymphocyte ratio index in early-stage hepatocellular carcinoma after hepatectomy: A propensity-score matched analysis.
Chen Y; He C; Wen T; Yan L; Yang J
Asia Pac J Clin Oncol; 2021 Oct; 17(5):e238-e248. PubMed ID: 33124200
[TBL] [Abstract][Full Text] [Related]
8. Stratified aspartate aminotransferase-to-platelet ratio index accurately predicts survival in hepatocellular carcinoma patients undergoing curative liver resection.
Yang HJ; Jiang JH; Yang YT; Guo Z; Li JJ; Liu XH; Lu F; Zeng FH; Ye JS; Zhang KL; Chen NZ; Xiang BD; Li LQ
Tumour Biol; 2017 Mar; 39(3):1010428317695944. PubMed ID: 28351330
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: A systematic review and meta-analysis.
Wang Y; Peng C; Cheng Z; Wang X; Wu L; Li J; Huang C; Guo Q; Cai H
Int J Surg; 2018 Jul; 55():73-80. PubMed ID: 29787804
[TBL] [Abstract][Full Text] [Related]
10. Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals.
Casadei Gardini A; Foschi FG; Conti F; Petracci E; Vukotic R; Marisi G; Buonfiglioli F; Vitale G; Ravaioli F; Gitto S; Verucchi G; Lenzi M; Bolondi L; Mazzella G; Brillanti S; Andreone P;
Dig Liver Dis; 2019 May; 51(5):681-688. PubMed ID: 30327251
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of platelet to lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.
Ma W; Zhang P; Qi J; Gu L; Zang M; Yao H; Shi X; Wang C; Jiang Y
Sci Rep; 2016 Oct; 6():35378. PubMed ID: 27739490
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
[TBL] [Abstract][Full Text] [Related]
14. King's score as a novel prognostic model for patients with hepatitis B-associated hepatocellular carcinoma.
Pang Q; Bi JB; Xu XS; Liu SS; Zhang JY; Zhou YY; Qu K; Liu C
Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1337-46. PubMed ID: 26275082
[TBL] [Abstract][Full Text] [Related]
15. The Prognostic Value of aspartate aminotransferase to lymphocyte ratio and systemic immune-inflammation index for Overall Survival of Hepatocellular Carcinoma Patients Treated with palliative Treatments.
Zhao LY; Yang DD; Ma XK; Liu MM; Wu DH; Zhang XP; Ruan DY; Lin JX; Wen JY; Chen J; Lin Q; Dong M; Qi JJ; Hu PS; Zeng ZL; Chen ZH; Wu XY
J Cancer; 2019; 10(10):2299-2311. PubMed ID: 31258733
[No Abstract] [Full Text] [Related]
16. Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.
Xiao WK; Chen D; Li SQ; Fu SJ; Peng BG; Liang LJ
BMC Cancer; 2014 Feb; 14():117. PubMed ID: 24559042
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory Scores: Correlation with Clinical Outcomes in Hepatocellular Carcinoma Patients Undergoing Transarterial Radioembolization.
Young S; Rubin N; D'Souza D; Sharma P; Pontolillo J; Flanagan S; Golzarian J; Sanghvi T
Cardiovasc Intervent Radiol; 2022 Apr; 45(4):461-475. PubMed ID: 35178599
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
[TBL] [Abstract][Full Text] [Related]
19. Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection.
Mao S; Yu X; Sun J; Yang Y; Shan Y; Sun J; Mugaanyi J; Fan R; Wu S; Lu C
BMC Cancer; 2022 Mar; 22(1):249. PubMed ID: 35255845
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of Pretreatment Apolipoprotein A-I as a Noninvasive Biomarker in Cancer Survivors: A Meta-Analysis.
Zhang Y; Yang X
Dis Markers; 2018; 2018():1034037. PubMed ID: 30510601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
